Fingolimod
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4501 publications
Infection Risk and Vaccine Considerations in Multiple Sclerosis and Related Disorders.
Journal: Continuum (Minneapolis, Minn.)
Published: April 02, 2026
Repeatedly occurring retrograde menstruation intensifies central sensitization driven by neuroinflammation in endometriosis models.
Journal: The Journal of clinical investigation
Published: March 17, 2026
Polypharmacologic phosphoinositide modulation by FTY720 triggers endomembrane trafficking collapse and metabolic starvation in cancer cells.
Journal: Biochemical and biophysical research communications
Published: March 05, 2026
Sphingosine-1-phosphate (S1P) signaling as a novel therapeutic target for alcohol abuse.
Journal: Research square
Published: February 27, 2026
Discovery of Novel Selective Dual Agonists Targeting S1PR1 and S1PR5 for the Treatment of Inflammatory Bowel Disease.
Journal: Journal of medicinal chemistry
Published: February 19, 2026
Natalizumab exacerbates astrocytopathy in NMOSD via blockade of endothelial VCAM1-astrocytic integrin α4 interaction.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 11, 2026
Correction to "Blocking Sphingosine 1-phosphate Metabolism With Fingolimod Prevents the Progression of Vascular Smooth Muscle Cells Calcification in Chronic Kidney Disease".
Journal: Journal of cellular physiology
Published: February 09, 2026
Pediatric-Onset Multiple Sclerosis at Age 10 Following Nephrotic Syndrome: Early Recognition and Successful Treatment With Fingolimod.
Journal: Cureus
Published: February 05, 2026
Identification of Drug Repurposing Opportunities of Immunomodulatory Drugs for Inflammatory Bowel Disease Through Inverse Pharmacovigilance Signal Detection in the FAERS Database.
Journal: Journal of clinical medicine
Published: February 01, 2026
Graphene oxide-based fluorescent biosensor for high-throughput screening to discover SARS-CoV-2 RdRp inhibitors.
Journal: Journal of materials chemistry. B
Published: January 21, 2026
Disease-modifying therapy in pediatric multiple sclerosis.
Journal: Handbook of clinical neurology
Published: January 12, 2026
Antigen-specific CD8 T cells are generated and reactivated in the bone marrow following viral brain infections and impact the bone marrow niche.
Journal: bioRxiv : the preprint server for biology
Published: January 09, 2026
Last Updated: 04/28/2026